BioAge Labs BIOA Insider Ownership

Updated Oct 10, 2026

In the last 12 months, insiders at BioAge Labs made open-market sales of $7.79 million (440.69K shares) and bought no shares on the open market.

• BioAge Labs' open-market sales in the past 12 months came from 4 insiders; no insider bought.
• Kristen Fortney (Chief Executive Officer) led open-market sales of BioAge Labs stock over the past 12 months with $4.22 million (233.11K shares), most recently on January 13, 2026.
• The newest open-market trade among BioAge Labs insiders came on June 30, 2026, when Shane Barton (Principal Accounting Officer) made a sale of 20.22K shares for $509,176.
• In transactions other than open-market trades, BioAge Labs insiders acquired 219.12K shares through option exercises and conversions over the past 12 months.
• Business Quant data puts insider holdings in BIOA at 8.26Mn shares across insiders' latest Form 4 filings, or 18.05% of the 45.78Mn shares outstanding; that total is down 16.47% from 9.89Mn shares at the end of Q2 2026 and down 6.94% from 8.88Mn shares at the end of Q3 2025.
• BioAge Labs insiders hold 1.01Mn shares directly (12.27% of their total) and 7.25Mn shares (87.73%) indirectly, through entities such as trusts and partnerships.
• BIOA's insider total is spread across 5 insiders who have filed a Form 4 in the past two years.
• BioAge Labs' three biggest insider holders are Vijay Satyanand Pande (Director, 3.23Mn shares), James Healy (Director, 2.3Mn shares) and Patrick G. Enright (Director, 1.71Mn shares), based on their latest Form 4 filings.
• The largest insider, Vijay Satyanand Pande, holds 39.13% of BIOA's insider total.
• In the past year, 11 insiders of BioAge Labs submitted 24 Form 4 filings reporting trades, awards or other transactions.
• The insider holdings and trades above for BioAge Labs reflect Form 4 filings through July 1, 2026.